Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy

1. Zuazo, M.
2. Arasanz, H.
3. Fernández-Hinojal, G.
4. García-Granda, M.J.
5. Gato, M.
6. Bocanegra, A.
7. Martínez, M.
8. Hernández, B.
9. Teijeira, L.
10. Morilla, I.
11. Lecumberri, M.J.
12. Fernández de Lascoiti, A.
13. Vera, R.
14. Kochan, G.
15. Escors, D.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.15252/EMMM.201910293 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus